Lizobakt tab. d / suction No. 30

Release form, composition and packaging

Lozenges, white or yellowish-white, round, with a dividing line on one side and bevels on both sides, inclusions in the form of dark spots are possible.

1 tab.

lysozyme hydrochloride

20 mg

pyridoxine hydrochloride

10 mg

lactose monohydrate - 155.4 mg, tragacanth gum - 10 mg, magnesium stearate - 4 mg, sodium saccharinate - 0.5 mg, vanillin - 0.1 mg.

10 pieces.

- blisters (1) - cardboard packs.

10 pieces.

- blisters (3) - cardboard packs.

pharmachologic effect

Antiseptic combined composition for topical use.

The effect of the drug is due to its constituent components.

Lysozyme is an enzyme of a protein nature, it is used as an antiseptic due to its direct effect on gram-positive and gram-negative bacteria, as well as fungi and viruses.

Takes part in the regulation of local nonspecific immunity.

Pyridoxine has a protective effect on the oral mucosa (has an antiphthous effect).

Does not affect the pharmacodynamic properties of lysozyme. ''

Indications for use

Treatment of infectious and inflammatory diseases of the oral mucosa, gums and larynx:

gingivitis

stomatitis

catarrhal phenomena of the upper respiratory tract

aphthous ulceration

herpetic lesions of the oral mucosa (as part of complex therapy)

erosion of the oral mucosa of various etiologies.

Contraindications for use

hereditary lactose intolerance, lactase deficiency or glucose / galactose malabsorption syndrome

children under 3 years old

hypersensitivity to drug components.

Dosage regimen

The drug is used topically in the oral cavity.

Children aged 3-7 years - 1 tab.

3 times a day, children aged 7-12 years - 1 tab.

4 times a day

adults and children over 12 years old are prescribed 2 tab.

3-4 times a day.

The course of treatment is 8 days.

Lizobact® tablets should be slowly dissolving without chewing, keeping the melted mass of the tablet in the mouth as long as possible, until complete dissolution.

Overdose

Overdose symptoms are unlikely, may occur after use in doses significantly higher than therapeutic and are manifested by a feeling of numbness, tingling sensation, as well as loss of sensitivity in the upper and lower extremities.

Treatment: drinking plenty of fluids (forced diuresis).

Side effect

Possibly: allergic reactions.

Drug interactions

When used together, Lizobact enhances the effect of antibiotics, incl.

penicillin, chloramphenicol, nitrofurantoin, enhances the effect of diuretics, weakens the activity of levodopa.

Isoniazid, penicillamine, pyrazinamide, immunosuppressants, estrogens and oral contraceptives may increase the need for pyridoxine (antagonistic effect against pyridoxine or increased renal excretion).

Application during pregnancy and lactation

It is possible to use the drug Lizobact during pregnancy and lactation (breastfeeding).

Special instructions In case of an allergic reaction, the use of the drug must be discontinued.

In such cases, the patient should consult a doctor.

Name ENG

LYSOBACT

Clinical and pharmacological group

Antiseptic for local use in ENT practice and dentistry

ATX code

Other drugs

Dosage

20mg + 10mg

Structure

Active ingredients: lysozyme hydrochloride 20 mg

pyridoxine hydrochloride 10 mg Excipients: lactose monohydrate - 155.4 mg

gum tragacanth - 10 mg

magnesium stearate - 4 mg

sodium saccharinate - 0.5 mg

vanillin - 0.1 mg

Indications

Treatment of infectious and inflammatory diseases of the oral mucosa, gums and larynx: gingivitis stomatitis catarrhal phenomena of the upper respiratory tract aphthous ulceration herpetic lesions of the oral mucosa (as part of complex therapy) erosion of the oral mucosa of various etiologies.

INN / Active ingredient

Pyridoxine hydrochloride + lysozyme hydrochloride

Storage conditions and periods

At a temperature of 10-30 degrees.

Expiration date: 5 years

Contraindications

Contraindications to the use of hereditary lactose intolerance, lactase deficiency or glucose / galactose malabsorption syndrome children under 3 years of age hypersensitivity to drug components.

Specifications

Category

Sore throat

Scope of the drug

Dentistry

,

Ear, Throat, Nose

Release form

Tablet

Manufacturer country

Bosnia and Herzegovina

Package quantity, pcs

thirty

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Bosnalijek

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antiseptic

Anatomical and therapeutic characteristics

R02AA20 Other antiseptics

Dosage form

Lozenges

Dosage (volume) of the substance in the preparation

lysozyme hydrochloride 20 mg

pyridoxine hydrochloride 10 mg

Expiration date in days

1825

The target audience

Children

Package weight, g

twenty

Mode of application

:

Topically. < br> The tablets should be slowly dissolved without chewing, keeping the melted mass of the tablet in the mouth as long as possible, until it is completely dissolved. < br> Children aged 3–7 years are usually prescribed 1 tablet 3 times a day, 7– 12 years old - 1 tablet 4 times a day.

Adults and children over the age of 12 - 2 tablets 3-4 times a day. < br> The course of treatment is 8 days.

Information on technical characteristics, delivery set, country of manufacture